A structural equation model to examine the clinical features of mild‐to‐moderate COVID19: A multicenter Italian study

MR Barillari, L Bastiani, JR Lechien… - Journal of medical …, 2021 - Wiley Online Library
… This study evaluates the clinical features of mild-to-moderate COVID-19 in a sample of
adult Italian patients. The structural equation model (SEM) built to examine the clinical …

Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study

F Cantini, L Niccoli, C Nannini, D Matarrese… - Journal of …, 2020 - journalofinfection.com
… , longitudinal multicenter-study in consecutive-hospitalized patients with COVID-19 moderate
… Clinical charts of patients with moderate COVID-19 pneumonia from 7 Italian hospitals (…

The clinical spectrum of COVID-19–associated cutaneous manifestations: An Italian multicenter study of 200 adult patients

…, K Peris, P Calzavara-Pinton, E Berti, IS COVID - Journal of the American …, 2021 - Elsevier
… for age, significantly associated with less severe COVID-19 (P = .0009). However, the …
moderate/severe COVID-19 were more represented than those with asymptomatic/mild COVID-19

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

A Di Castelnuovo, S Costanzo, A Antinori… - European Journal of …, 2020 - Elsevier
… Drug Agency (AIFA) stated in this emergency phase that therapeutic use of HCQ might be
considered in COVID-19 patients, both in those with mild presentation managed at home and …

… characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

F Passamonti, C Cattaneo, L Arcaini, R Bruna… - The Lancet …, 2020 - thelancet.com
… The aim of the Italian Hematology Alliance on COVID-19 (ITA-HEMA-COV) project was to …
hospitalisation for COVID-19. Here, we report results from a cohort study of 66 hospitals in Italy. …

Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicenter Italian CORIST study

A Di Castelnuovo, S Costanzo… - Thrombosis and …, 2021 - thieme-connect.com
… a large cohort of Italian COVID-19 patients. Methods In a retrospective observational study,
2,574 unselected patients hospitalized in 30 clinical centers in Italy from February 19, 2020 to …

… phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19

E Nicastri, F Marinangeli, E Pivetta, E Torri… - …, 2022 - thelancet.com
… To the best of our knowledge, this is the first multicenter, … in adult patients with mild to moderate
COVID-19. The proportion … study was planned to be performed at 10 sites including Italy

Olfactory and gustatory function impairment in COVID19 patients: Italian objective multicenterstudy

LA Vaira, C Hopkins, G Salzano, M Petrocelli… - Head & …, 2020 - Wiley Online Library
… of the disease, paucisymptomatic or with mild and moderate forms of COVID-19. To overcome
this … In this study, we report and analyze the results of a large Italian multicenter study that …

[HTML][HTML] Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma. A proof-of-concept, single-arm, multicenter trial

C Perotti, F Baldanti, R Bruno, C Del Fante… - …, 2020 - ncbi.nlm.nih.gov
… , one-arm, multicenter interventional study on the short-term (… plasma in COVID-19 patients
with moderately to severely … patients in Italy at the time of designing the study and when …

Risk factors for mortality in COVID-19 hospitalized patients in Piedmont, Italy: results from the multicenter, regional, CORACLE registry

FG De Rosa, A Palazzo, T Rosso, N Shbaklo… - Journal of Clinical …, 2021 - mdpi.com
… -19 hospital patients who have not been given, or up to 4 L/min of, extra oxygen. In a … study
published, 667 persons did not boost their clinical status in a mild- to medium-size COVID-19